| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |